BABA vs THRM

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

THRM presents a contradictory profile: a stable balance sheet paired with deteriorating earnings performance. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $29.58 trades at a significant premium to both the Graham Number ($17.7) and the growth-based Intrinsic Value ($4.13). While the Forward P/E of 9.58 suggests a massive expected earnings recovery, the current YoY earnings crash of -81.20% and a bearish technical trend create significant near-term risk. The investment thesis relies entirely on a turnaround in profitability that has not yet materialized in the data.